Abstract
Personalized medicine aims to utilize genomic information about patients to tailor treatment. Gene replacement therapy for rare genetic disorders is perhaps the most extreme form of personalized medicine, in that the patients’ genome wholly determines their treatment regimen. Gene therapy for retinal disorders is poised to become a clinical reality. The eye is an optimal site for gene therapy due to the relative ease of precise vector delivery, immune system isolation, and availability for monitoring of any potential damage or side effects. Due to these advantages, clinical trials for gene therapy of retinal diseases are currently underway. A necessary precursor to such gene therapies is accurate molecular diagnosis of the mutation(s) underlying disease. In this review, we discuss the application of Next Generation Sequencing (NGS) to obtain such a diagnosis and identify disease causing genes, using retinal disorders as a case study. After reviewing ocular gene therapy, we discuss the application of NGS to the identification of novel Mendelian disease genes. We then compare current, array based mutation detection methods against next NGS-based methods in three retinal diseases: Leber’s Congenital Amaurosis, Retinitis Pigmentosa, and Stargardt’s disease. We conclude that next-generation sequencing based diagnosis offers several advantages over array based methods, including a higher rate of successful diagnosis and the ability to more deeply and efficiently assay a broad spectrum of mutations. However, the relative difficulty of interpreting sequence results and the development of standardized, reliable bioinformatic tools remain outstanding concerns. In this review, recent advances NGS based molecular diagnoses are discussed, as well as their implications for the development of personalized medicine.
Article PDF
Similar content being viewed by others
References
Meyer U A. Personalized medicine: a personal view. Clin Pharmacol Ther, 2012, 91: 373–375
Sieving P A, Caruso R C, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA, 2006, 103: 3896–3901
Nguyen Q D, Schachar R A, Nduaka C I, et al. Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients. Eye, 2012
Hauswirth W W, Aleman T S, Kaushal S, et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther, 2008, 19: 979–990
Cideciyan A V, Aleman T S, Boye S L, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA, 2008, 105: 15112–15117
Bainbridge J W B, Smith A J, Barker S S, et al. Effect of gene therapy on visual function in Leber’s Congenital Amaurosis. N Engl J Med, 2008, 358: 2231–2239
Maguire A M, Simonelli F, Pierce E A, et al. Safety and efficacy of gene transfer for Leber’s Congenital Amaurosis. N Engl J Med, 2008, 358: 2240–2248
Bennett J, Ashtari M, Wellman J, et al. AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med, 2012, 4: 120ra15
Kinnunen K, Yla-Herttuala S. Gene therapy in age related macular degeneration and hereditary macular disorders. Front Biosci (Elite Ed), 2012, 4: 2546–2557
Carter-Dawson L D, LaVail M M, Sidman R L. Differential effect of the rd mutation on rods and cones in the mouse retina. Invest Ophthalmol Vis Sci, 1978, 17: 489–498
Weng J, Mata N L, Azarian S M, et al. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt’s disease from the phenotype in abcr knockout mice. Cell, 1999, 98: 13–23
Lem J, Flannery J G, Li T, et al. Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase beta subunit. Proc Natl Acad Sci USA, 1992, 89: 4422–4426
Bennett J, Tanabe T, Sun D, et al. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med, 1996, 2: 649–654
Palfi A, Millington-Ward S, Chadderton N, et al. Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene. Hum Gene Ther, 2010, 21: 311–323
Koch S, Sothilingam V, Garrido M G, et al. Gene therapy restores vision and delays degeneration in the CNGB1-/- mouse model of retinitis pigmentosa. Hum Mol Genet, 2012
Zhang K, Zhang L, Weinreb R N. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov, 2012, 11: 541–559
Daiger S P. Retinal Information Network. https://sph.uth.tmc.edu/retnet/, 1996
den Hollander A I, Roepman R, Koenekoop R K, et al. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res, 2008, 27: 391–419
Neveling K, Collin R W, Gilissen C, et al. Next-generation genetic testing for retinitis pigmentosa. Hum Mutat, 33: 963–972
O’sullivan J, Mullaney B G, Bhaskar S S, et al. A paradigm shift in the delivery of services for diagnosis of inherited retinal disease. J Med Genet, 49: 322–326
Niederkorn J Y. Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? Front Immunol, 2012, 3: 148
Friedmann T, Roblin R. Gene therapy for human genetic disease? Science, 1972, 175: 949–955
Liu M M, Tuo J, Chan C C. Gene therapy for ocular diseases. Br J Ophthalmol, 2011, 95: 604–612
Samulski R J, Berns K I, Tan M, et al. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci USA, 1982, 79: 2077–2081
Hermonat P L, Muzyczka N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA, 1984, 81: 6466–6470
Mori S, Wang L, Takeuchi T, et al. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology, 2004, 330: 375–383
Klimczak R R, Koerber J T, Dalkara D, et al. A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Muller cells. PLoS ONE, 2009, 4: e7467
Zhong L, Li B, Mah C S, et al. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci USA, 2008, 105: 7827–7832
Vandenberghe L H, Auricchio A. Novel adeno-associated viral vectors for retinal gene therapy. Gene Ther, 2012, 19: 162–168
Petrs-Silva H, Dinculescu A, Li Q, et al. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther, 2008, 17: 463–471
Kolstad K D, Dalkara D, Guerin K, et al. Changes in adeno-associated virus-mediated gene delivery in retinal degeneration. Hum Gene Ther, 2010, 21: 571–578
Auricchio A, Kobinger G, Anand V, et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet, 2001, 10: 3075–3081
Pang J J, Dai X, Boye S E, et al. Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa. Mol Ther, 2011, 19: 234–242
Deng W T, Dinculescu A, Li Q, et al. Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats. Invest Ophthalmol Vis Sci, 2012, 53: 1895–1904
Acland G M, Aguirre G D, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet, 2001, 28: 92–95
Mancuso K, Hauswirth W W, Li Q, et al. Gene therapy for red-green colour blindness in adult primates. Nature, 2009, 461: 784–787
Yang Y, Mohand-Said S, Danan A, et al. Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa. Mol Ther, 2009, 17: 787–795
Min S H, Molday L L, Seeliger M W, et al. Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of X-linked juvenile retinoschisis. Mol Ther, 2005, 12: 644–651
Beltran W A, Cideciyan A V, Lewin A S, et al. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. Proc Natl Acad Sci USA, 2012, 109: 2132–2137
Koilkonda R D, Chou T H, Porciatti V, et al. Induction of rapid and highly efficient expression of the human nd4 complex i subunit in the mouse visual system by self-complementary adeno-associated virus. Arch Ophthalmol, 2010, 128: 876–883
Zhang K, Hopkins J J, Heier J S, et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci USA, 2011, 108: 6241–6245
Schwartz S D, Hubschman J P, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet, 2012, 379: 713–720
Seiler M J, Aramant R B. Cell replacement and visual restoration by retinal sheet transplants. Prog Ret Eye Res, 2012, http://dx.doi.org/10.1016/j.preteyeres.2012.06.003
Tibbetts M D, Samuel M A, Chang T S, et al. Stem cell therapy for retinal disease. Curr Opin Ophthalmol, 2012, 23: 226–234
Phillips M I. Gene, stem cell, and future therapies for orphan diseases. Clin Pharmacol Ther, 2012, 92: 182–192
Koenekoop R K, Lopez I, den Hollander A I, et al. Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions. Clin Experiment Ophthalmol, 2007, 35: 473–485
Riordan J R, Rommens J M, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 1989, 245: 1066–1073
Gusella J F, Wexler N S, Conneally P M, et al. A polymorphic DNA marker genetically linked to Huntington’s disease. Nature, 1983, 306: 234–238
Ng S B, Buckingham K J, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet, 2010, 42: 30–35
Rabbani B, Mahdieh N, Hosomichi K, et al. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. J Hum Genet, 2012, 57: 621–632
Wang Y, Guo L, Cai S P, et al. Exome sequencing identifies compound heterozygous mutations in CYP4V2 in a pedigree with retinitis pigmentosa. PLoS ONE, 2012, 7: e33673
Hughes A E, Meng W, Lotery A J, et al. A novel GUCY2D mutation, V933A, causes central areolar choroidal dystrophy. Invest Ophthalmol Vis Sci, 2012, 53: 4748–4753
Koenekoop R K, Wang H, Majewski J, et al. Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration. Nat Genet, 2012, 44: 1035–1039
Zhi D, Chen R. Statistical guidance for experimental design and data analysis of mutation detection in rare monogenic mendelian diseases by exome sequencing. PLoS ONE, 2012, 7: e31358
Bowne S J, Sullivan L S, Mortimer S E, et al. Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis. Invest Ophthalmol Vis Sci, 2006, 47: 34–42
den Hollander A I, Heckenlively J R, van den Born L I, et al. Leber congenital amaurosis and retinitis pigmentosa with Coats-like exudative vasculopathy are associated with mutations in the crumbs homologue 1 (CRB1) gene. Am J Hum Genet, 2001, 69: 198–203
den Hollander A I, Koenekoop R K, Mohamed M D, et al. Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis. Nat Genet, 2007, 39: 889–895
den Hollander A I, Koenekoop R K, Yzer S, et al. Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. Am J Hum Genet, 2006, 79: 556–561
Dryja T P, Adams S M, Grimsby J L, et al. Null RPGRIP1 alleles in patients with Leber congenital amaurosis. Am J Hum Genet, 2001, 68: 1295–1298
Estrada-Cuzcano A, Koenekoop R K, Coppieters F, et al. IQCB1 mutations in patients with Leber congenital amaurosis. Invest Ophthalmol Vis Sci, 2011, 52: 834–839
Freund C L, Wang Q L, Chen S, et al. De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis. Nat Genet, 1998, 18: 311–312
Friedman J S, Chang B, Kannabiran C, et al. Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration. Am J Hum Genet, 2006, 79: 1059–1070
Henderson R H, Williamson K A, Kennedy J S, et al. A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction. Mol Vis, 2009, 15: 2442–2447
Janecke A R, Thompson D A, Utermann G, et al. Mutations in RDH12 encoding a photoreceptor cell retinol dehydrogenase cause childhood-onset severe retinal dystrophy. Nat Genet, 2004, 36: 850–854
Marlhens F, Bareil C, Griffoin J M, et al. Mutations in RPE65 cause Leber’s congenital amaurosis. Nat Genet, 1997, 17: 139–141
Mataftsi A, Schorderet D F, Chachoua L, et al. Novel TULP1 mutation causing leber congenital amaurosis or early onset retinal degeneration. Invest Ophthalmol Vis Sci, 2007, 48: 5160–5167
Perrault I, Hanein S, Gerber S, et al. Retinal dehydrogenase 12 (RDH12) mutations in leber congenital amaurosis. Am J Hum Genet, 2004, 75: 639–646
Perrault I, Rozet J M, Calvas P, et al. Retinal-specific guanylate cyclase gene mutations in Leber’s congenital amaurosis. Nat Genet, 1996, 14: 461–464
Sohocki M M, Bowne S J, Sullivan L S, et al. Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis. Nat Genet, 2000, 24: 79–83
Stone E M, Cideciyan A V, Aleman T S, et al. Variations in NPHP5 in patients with nonsyndromic leber congenital amaurosis and Senior-Loken syndrome. Arch Ophthalmol, 2011, 129: 81–87
Wang H, den Hollander A I, Moayedi Y, et al. Mutations in SPATA7 cause Leber congenital amaurosis and juvenile retinitis pigmentosa. Am J Hum Genet, 2009, 84: 380–387
Sergouniotis P I, Davidson A E, Mackay D S, et al. Recessive mutations in KCNJ13, encoding an inwardly rectifying potassium channel subunit, cause leber congenital amaurosis. Am J Hum Genet, 2011, 89: 183–190
Daiger P, Rossiter B, Greenberg J, et al. Data services and software for identifying genes and mutations causing retinal degeneration. 1998, 39: 2
Xi Q, Li L, Traboulsi E I, et al. Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease. Mol Vis, 2009, 15: 638–645
Kurg A, Tonisson N, Georgiou I, et al. Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology. Genet Test, 2000, 4: 1–7
Henderson R H, Waseem N, Searle R, et al. An assessment of the apex microarray technology in genotyping patients with Leber congenital amaurosis and early-onset severe retinal dystrophy. Invest Ophthalmol Vis Sci, 2007, 48: 5684–5689
Yzer S, Leroy B P, De Baere E, et al. Microarray-based mutation detection and phenotypic characterization of patients with Leber congenital amaurosis. Invest Ophthalmol Vis Sci, 2006, 47: 1167–1176
Zernant J, Kulm M, Dharmaraj S, et al. Genotyping microarray (disease chip) for Leber congenital amaurosis: detection of modifier alleles. Invest Ophthalmol Vis Sci, 2005, 46: 3052–3059
Bogni S, Schoni D, Constantinescu M, et al. Tissue fusion, a new opportunity for sutureless bypass surgery. Acta Neurochir Suppl, 2011, 112: 45–53
Avila-Fernandez A, Cantalapiedra D, Aller E, et al. Mutation analysis of 272 Spanish families affected by autosomal recessive retinitis pigmentosa using a genotyping microarray. Mol Vis, 2010, 16: 2550–2558
Blanco-Kelly F, Garcia-Hoyos M, Corton M, et al. Genotyping microarray: mutation screening in Spanish families with autosomal dominant retinitis pigmentosa. Mol Vis, 2012, 18: 1478–1483
Allard R E. Retinitis pigmentosa—an overview. J Am Optom Assoc, 1983, 54: 793–800
Franceschetti A, Dieterle P. Diagnostic and prognostic importance of the electroretinogram in tapetoretinal degeneration with reduction of the visual field and hemeralopia. Confin Neurol, 1954, 14: 184–186
Dharmaraj S R, Silva E R, Pina A L, et al. Mutational analysis and clinical correlation in Leber congenital amaurosis. Ophthalmic Genet, 2000, 21: 135–150
Stone E M. Leber congenital amaurosis—a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. Am J Ophthalmol, 2007, 144: 791–811
Xu F, Dong Q, Liu L, et al. Novel RPE65 mutations associated with Leber congenital amaurosis in Chinese patients. Mol Vis, 2012, 18: 744–750
Seong M W, Kim S Y, Yu Y S, et al. Molecular characterization of Leber congenital amaurosis in Koreans. Mol Vis, 2008, 14: 1429–1436
Downs K, Zacks D N, Caruso R, et al. Molecular testing for hereditary retinal disease as part of clinical care. Arch Ophthalmol, 2007, 125: 252–258
Zernant J, Schubert C, Im K M, et al. Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci, 2011, 52: 8479–8487
Coppieters F, De Wilde B, Lefever S, et al. Massively parallel sequencing for early molecular diagnosis in Leber congenital amaurosis. Genet Med, 2012, 14: 576–585
Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis, 2006, 1: 40
Piersma A H, Hernandez L G, van Benthem J, et al. Reproductive toxicants have a threshold of adversity. Crit Rev Toxicol, 2011, 41: 545–554
Pagon R A, Daiger S P. Retinitis pigmentosa overview. In: Pagon R A, Bird T D, Dolan C R, et al., eds. GeneReviews. Seattle: University of Washington, 1993
Sohocki M M, Daiger S P, Bowne S J, et al. Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat, 2001, 17: 42–51
de Bie M K, van Rees J B, Herzog C A, et al. How to reduce the incidence of contrast induced acute kidney injury after cardiac invasive procedures, a review and practical recommendations. Curr Med Res Opin, 2011, 27: 1347–1357
Gonzalez-Rodriguez M L, Rabasco A M. Charged liposomes as carriers to enhance the permeation through the skin. Expert Opin Drug Deliv, 2011, 8: 857–871
Vijverberg S J, Koenderman L, Koster E S, et al. Biomarkers of therapy responsiveness in asthma: pitfalls and promises. Clin Exp Allergy, 2011, 41: 615–629
Burke T R, Tsang S H. Allelic and phenotypic heterogeneity in ABCA4 mutations. Ophthalmic Genet, 2011, 32: 165–174
Kaplan J, Gerber S, Larget-Piet D, et al. A gene for Stargardt’s disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat Genet, 1993, 5: 308–311
Edwards A O, Donoso L A, Ritter R 3rd. A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family. Invest Ophthalmol Vis Sci, 2001, 42: 2652–2663
Vrabec T R, Tantri A, Edwards A, et al. Autosomal dominant Stargardt-like macular dystrophy: identification of a new family with a mutation in the ELOVL4 gene. Am J Ophthalmol, 2003, 136: 542–545
Kniazeva M, Chiang M F, Morgan B, et al. A new locus for autosomal dominant stargardt-like disease maps to chromosome 4. Am J Hum Genet, 1999, 64: 1394–1399
Quazi F, Lenevich S, Molday R S. ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer. Nat Commun, 2012, 3: 925
Dornstauder B, Suh M, Kuny S, et al. Dietary docosahexaenoic acid supplementation prevents age-related functional losses and A2E accumulation in the retina. Invest Ophthalmol Vis Sci, 2012, 53: 2256–2265
Rozet J M, Gerber S, Ghazi I, et al. Mutations of the retinal specific ATP binding transporter gene (ABCR) in a single family segregating both autosomal recessive retinitis pigmentosa RP19 and Stargardt disease: evidence of clinical heterogeneity at this locus. J Med Genet, 1999, 36: 447–451
Jaakson K, Zernant J, Kulm M, et al. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum Mutat, 2003, 22: 395–403
Ernest P J, Boon C J, Klevering B J, et al. Outcome of ABCA4 microarray screening in routine clinical practice. Mol Vis, 2009, 15: 2841–2847
Webster A R, Heon E, Lotery A J, et al. An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci, 2001, 42: 1179–1189
Zaremba C M, Wiszniewski W, Lewis R A, et al. Identification of ABCA4 regulatory mutations in Stargart families. Invest Ophthalmol Vis Sci, 2005, 46: 1794
Richards A J, McNinch A, Whittaker J, et al. Splicing analysis of unclassified variants in COL2A1 and COL11A1 identifies deep intronic pathogenic mutations. Eur J Hum Genet, 2012, 20: 552–558
Klambauer G, Schwarzbauer K, Mayr A, et al. cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate. Nucleic Acids Res, 2012, 40: e69
Nelson M R, Wegmann D, Ehm M G, et al. An abundance of rare functional variants in 202 drug target genes sequenced in 14002 people. Science, 2012, 337: 100–104
Human Genomics Strategy Group. Building on our inheritance: genomic technology in healthcare. United Kindgom Department of Health, 2012
Camerlengo T, Ozer H G, Onti-Srinivasan R, et al. From sequencer to supercomputer: an automatic pipeline for managing and processing next generation sequencing data. AMIA Summits Transl Sci Proc, 2012, 1–10
Liu L, Li Y, Li S, et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol, 2012, 251364
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Zaneveld, J., Wang, F., Wang, X. et al. Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease. Sci. China Life Sci. 56, 125–133 (2013). https://doi.org/10.1007/s11427-013-4443-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4443-y